Inflammation-Modulating Hydrogels for Osteoarthritis Cartilage Tissue Engineering

Гидрогели, модулирующие воспаление, для тканевой инженерии хряща при остеоартрите
Yinji Jin, Nathaniel Suk-Yeon Hwang, Ji‐Soo Kim, Rachel H. Koh
2020-02-12

cartilage tissue engineeringimmunomodulatory biomaterialsinflammation-modulating hydrogelsinjectable and adhesive hydrogelsosteoarthritis
Osteoarthritis (OA) is the most common form of the joint disease associated with age, obesity, and traumatic injury. It is a disabling degenerative disease that affects synovial joints and leads to cartilage deterioration. Despite the prevalence of this disease, the understanding of OA pathophysiology is still incomplete. However, the onset and progression of OA are heavily associated with the inflammation of the joint. Therefore, studies on OA treatment have sought to intra-articularly deliver anti-inflammatory drugs, proteins, genes, or cells to locally control inflammation in OA joints. These therapeutics have been delivered alone or increasingly, in delivery vehicles for sustained release. The use of hydrogels in OA treatment can extend beyond the delivery of anti-inflammatory components to have inherent immunomodulatory function via regulating immune cell polarization and activity. Currently, such immunomodulatory biomaterials are being developed for other applications, which can be translated into OA therapy. Moreover, anabolic and proliferative levels of OA chondrocytes are low, except initially, when chondrocytes temporarily increase anabolism and proliferation in response to structural changes in their extracellular environment. Therefore, treatments need to restore matrix protein synthesis and proliferation to healthy levels to reverse OA-induced damage. In conjugation with injectable and/or adhesive hydrogels that promote cartilage tissue regeneration, immunomodulatory tissue engineering solutions will have robust potential in OA treatment. This review describes the disease, its current and future immunomodulatory therapies as well as cartilage-regenerative injectable and adhesive hydrogels.
1
Combining immunomodulatory biomaterials with injectable or adhesive cartilage-regenerative hydrogels could offer robust tissue-engineering approaches for OA treatment.
2
Effective OA cartilage repair must restore reduced chondrocyte matrix-protein synthesis and proliferation toward healthy levels.
3
Hydrogels may provide inherent immunomodulatory effects by regulating immune-cell polarization and activity, beyond serving as drug-delivery vehicles.
4
Intra-articular delivery of anti-inflammatory drugs, proteins, genes, or cells can locally modulate inflammation, with hydrogels enabling sustained therapeutic release.
5
Osteoarthritis progression is strongly associated with joint inflammation, making local inflammatory control a central therapeutic strategy.

Inflammation-modulating injectable and adhesive hydrogels for osteoarthritis cartilage tissue engineering

Immunomodulation and cartilage regeneration, including sustained therapeutic delivery, regulation of immune-cell polarization and activity, and restoration of chondrocyte matrix synthesis and proliferation

Publication Details
Publication Date
2020-02-12
Journal
Publisher
ISSN
Cited by
101
Access Type
Author Information
Authors
Yinji Jin
Nathaniel Suk-Yeon Hwang
Ji‐Soo Kim
Rachel H. Koh
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%